journal article·2021-04-14

Structural Disruptions of the Outer Membranes of Gram-Negative Bacteria by Rationally Designed Amphiphilic Antimicrobial Peptides

Haoning Gong, Xuzhi Hu, Mingrui Liao, Ke Fa, Daniela Ciumac, Luke A. Clifton, Marc-Antoine Sani, Stephen M. King, Armando Maestro, Frances Separovic, Thomas A. Waigh, Hai Xu, Andrew J. McBain, Jian Ren Lu

ACS Applied Materials & Interfaces· Volume 13· Issue 14
Publisher page

Abstract

Gram-negative bacteria are covered by both an inner cytoplasmic membrane (IM) and an outer membrane (OM). Antimicrobial peptides (AMPs) must first permeate through the OM and cell wall before attacking the IM to cause cytoplasmic leakage and kill the bacteria. The bacterial OM is an asymmetric bilayer with the outer leaflet primarily composed of lipopolysaccharides (LPSs) and the inner leaflet composed of phospholipids (PLs). Two cationic α-helical AMPs were designed to target Gram-negative bacteria, a full peptide G(IIKK)3I-NH2 (G3), and a hydrophobic lipopeptide C8-G(IIKK)2I-NH2 (C8G2, with C8 denoting the octanoyl chain). LPS dominates OM functions as the first line of defense against antibiotics, thereby reducing drug susceptibility. This work explores how the two AMPs interact with LPS through several carefully chosen OM models that facilitated measurements from solid-state nuclear magnetic resonance (ss-NMR), small-angle neutron scattering (SANS), and neutron reflectivity (NR). The results revealed that G3 molecules bound preferably to the LPS head region and functioned as bridge molecules to reassemble the dislocated lipids into bilayer stacks. In contrast, C8G2 lipopeptides could quickly penetrate into the central region of the OM to cause direct removal of some membrane lipids. Different structural disruptions implicated different antimicrobial efficacies from these AMPs. The demonstration of the structural features underlying different susceptibilities of the OM to AMPs offers a useful route for the future development of strain-specific AMPs against antimicrobial-resistant pathogens.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Lipid Membrane Structure and Behavior · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biological Physics Laboratory, Department of Physics and Astronomy, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK

Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK

ISIS Pulsed Neutron & Muon Source, STFC Rutherford Appleton Laboratory, Harwell Campus, Didcot OX11 0QX, UK

School of Chemistry, Bio21 Institute, University of Melbourne, Melbourne, VIC 3010, Australia

Institute Laue Langevin, 71 Avenue des Martyrs, CS-20156, 38042 Grenoble, France

State Key Laboratory of Heavy Oil Processing and the Centre for Bioengineering and Biotechnology, China University of Petroleum (East China), 66 Changjiang West Road, Qingdao 266580, China

Funding

AstraZeneca · University of Manchester · Innovate UK · China Scholarship Council · Biotechnology and Biological Sciences Research Council

References (54)

Show source-provided references
1. 10.1016/S0140-6736(11)60401-710.1016/S0140-6736(11)60401-7 ↗
2. 10.1016/S1473-3099(13)70318-910.1016/S1473-3099(13)70318-9 ↗
3. 10.1038/415389a10.1038/415389a ↗
4. 10.1038/s41573-019-0058-810.1038/s41573-019-0058-8 ↗
5. 10.1124/pr.55.1.210.1124/pr.55.1.2 ↗
6. 10.1016/j.amjmed.2006.03.01110.1016/j.amjmed.2006.03.011 ↗
7. 10.1126/science.aau548010.1126/science.aau5480 ↗
8. 10.1016/j.jcis.2018.10.10310.1016/j.jcis.2018.10.103 ↗
9. 10.1038/s41564-018-0164-010.1038/s41564-018-0164-0 ↗
10. 10.1016/j.colsurfb.2016.10.04310.1016/j.colsurfb.2016.10.043 ↗
11. 10.1021/acsomega.7b0127010.1021/acsomega.7b01270 ↗
12. 10.1021/acsami.0c0993110.1021/acsami.0c09931 ↗
13. 10.1021/jacs.8b1193910.1021/jacs.8b11939 ↗
14. 10.1073/pnas.060507910310.1073/pnas.0605079103 ↗
15. 10.1016/S0006-3495(01)75802-X10.1016/S0006-3495(01)75802-X ↗
16. 10.1021/bi962062110.1021/bi9620621 ↗
17. 10.1039/c2cp43099a10.1039/c2cp43099a ↗
18. 10.1073/pnas.180397511510.1073/pnas.1803975115 ↗
19. 10.1038/s41467-019-11503-310.1038/s41467-019-11503-3 ↗
20. 10.1038/nature1346410.1038/nature13464 ↗
21. 10.1038/nrmicro.2016.2510.1038/nrmicro.2016.25 ↗
22. 10.1146/annurev.biochem.71.110601.13541410.1146/annurev.biochem.71.110601.135414 ↗
23. 10.1021/la504407v10.1021/la504407v ↗
24. 10.1016/j.mib.2013.09.00710.1016/j.mib.2013.09.007 ↗
25. 10.1073/pnas.110692710810.1073/pnas.1106927108 ↗
26. 10.1038/nature1272910.1038/nature12729 ↗
27. 10.1016/0019-2791(76)90181-610.1016/0019-2791(76)90181-6 ↗
28. 10.1021/bm201098j10.1021/bm201098j ↗
29. 10.1016/j.biomaterials.2013.10.08210.1016/j.biomaterials.2013.10.082 ↗
30. 10.1021/am504973d10.1021/am504973d ↗
31. 10.1021/acs.langmuir.9b0377410.1021/acs.langmuir.9b03774 ↗
32. 10.1021/acsami.0c1722210.1021/acsami.0c17222 ↗
33. 10.1021/bm400356m10.1021/bm400356m ↗
34. 10.1098/rsif.2013.081010.1098/rsif.2013.0810 ↗
35. 10.1128/MMBR.67.4.593-656.200310.1128/MMBR.67.4.593-656.2003 ↗
36. 10.1111/j.1432-1033.1969.tb00601.x10.1111/j.1432-1033.1969.tb00601.x ↗
37. 10.1038/nprot.2007.52110.1038/nprot.2007.521 ↗
38. 10.1038/nnano.2010.2910.1038/nnano.2010.29 ↗
39. 10.1016/S0014-5793(99)00443-310.1016/S0014-5793(99)00443-3 ↗
40. 10.1021/acsami.9b1002810.1021/acsami.9b10028 ↗
41. 10.1016/j.jcis.2018.07.03110.1016/j.jcis.2018.07.031 ↗
42. 10.1016/j.jcis.2019.01.05610.1016/j.jcis.2019.01.056 ↗
43. 10.1016/j.jcis.2019.08.09810.1016/j.jcis.2019.08.098 ↗
44. 10.1016/j.bbamem.2020.18320410.1016/j.bbamem.2020.183204 ↗
45. 10.1016/j.physb.2006.05.40010.1016/j.physb.2006.05.400 ↗
46. 10.1140/epjp/i2011-11107-810.1140/epjp/i2011-11107-8 ↗
47. 10.1107/S002188980600507310.1107/S0021889806005073 ↗
48. 10.1016/S1473-3099(01)00092-510.1016/S1473-3099(01)00092-5 ↗
49. 10.1038/nprot.2006.20410.1038/nprot.2006.204 ↗
50. 10.1021/acs.langmuir.7b0363910.1021/acs.langmuir.7b03639 ↗
51. 10.1021/acs.accounts.6b0007410.1021/acs.accounts.6b00074 ↗
52. 10.1021/acs.langmuir.6b0024010.1021/acs.langmuir.6b00240 ↗
53. 10.1038/s41467-017-01447-x10.1038/s41467-017-01447-x ↗
54. 10.1021/acsami.8b0741710.1021/acsami.8b07417 ↗